Zobrazeno 1 - 10
of 98
pro vyhledávání: '"C G Regårdh"'
Publikováno v:
European Journal of Clinical Pharmacology. 38:421-424
The biliary secretion of [14C]felodipine in 4 healthy human subjects was studied by use of the multiple marker dilution principle with double lumen tubes placed in the stomach and intestine. Insignificant amounts of 14C activity were recovered from g
Publikováno v:
Journal of pharmaceutical sciences. 89(1)
The objective of this study was a systematic characterization and evaluation of cell culture models based on mixtures of Caco-2/HT29-MTX co-cultures for their use in screening for drug absorption and intestinal permeability in comparison to the prope
Publikováno v:
Journal of pharmaceutical sciences. 88(10)
It has been shown in vivo and in vitro that P-glycoprotein (P-gp) may be able to influence the permeability of its substrates across biological membranes. However, the quantitative contribution of the secretion process mediated by P-gp on the overall
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 27(5)
Clevidipine is a new vascular selective calcium channel antagonist of the dihydropyridine type, structurally related to felodipine. Clinical trials have shown that the drug can be used to effectively control the blood pressure in connection with card
Autor:
S, Döppenschmitt, P, Langguth, C G, Regårdh, T B, Andersson, C, Hilgendorf, H, Spahn-Langguth
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 288(1)
Interaction with the exsorptive transporter P-glycoprotein (P-gp) is a possible source of peculiarities in drug pharmacokinetics, including dose-dependent absorption, drug-drug interactions, intestinal secretion, and limited permeability of the blood
Publikováno v:
Pharmaceutical research. 15(7)
To develop a rapid and reliable system for affinity determination of conventional as well as newly synthesized compounds to P-gp.The principles of radioligand-binding assay were adapted to the human intestinal P-gp. Acceptor protein was obtained from
Publikováno v:
Biopharmaceuticsdrug disposition. 19(1)
Pharmacokinetics, excretion, and metabolism of inogatran, a low-molecular-weight thrombin inhibitor, were studied in the rat, dog, and cynomolgus monkey. After intravenous administration the half-life was short in all three animal species, due to a s
Publikováno v:
European Journal of Clinical Pharmacology. 49
In this randomised, cross-over study, in nine healthy males given felodipine ER 10 mg PO 200 ml grapefruit juice was found to increase the plasma levels of felodipine even when the juice was taken 24 hours before the drug. Grapefruit juice drunk simu
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 266(1)
The central nervous and systemic kinetics of ramipril, an angiotensin-converting enzyme inhibitor prodrug, and its active metabolite ramiprilat were studied in conscious beagle dogs after sampling of cerebrospinal fluid (CSF) and blood during chronic
Autor:
H, Lennernäs, C G, Regårdh
Publikováno v:
Pharmaceutical research. 10(6)
Pafenolol is a beta-blocker with unusual oral absorption properties. The blood concentration-time profile exhibits two peaks, and the bioavailability is low and dose dependent because of incomplete and nonlinear intestinal uptake. We addressed the qu